Sharp Life Science

Sharp Life Science is a UK-based life science tools and medical device company developing microfluidics-enabled assay automation technology for life science and healthcare applications. Its core product platform, aQdrop, is a thin-film-transistor digital microfluidics system designed to precisely manipulate droplets for chemical and biological analysis. The company appears focused on enabling automated, reproducible laboratory workflows and point-of-need diagnostic applications rather than building a therapeutic drug pipeline. Sharp Life Science is an active private company incorporated in 2016 in the United Kingdom and is part of the broader Sharp corporate group. Its technology has been described in published scientific literature for molecular diagnostic workflows, including SARS-CoV-2 sample-to-answer proof-of-concept testing.